MCO (MyComplianceOffice) Rises to Number 17 on Chartis Research's Financial Crime and Compliance50 2026

MCO (MyComplianceOffice) Rises to Number 17 on Chartis Research's Financial Crime and Compliance50 2026

NEW YORK, March 10, 2026 /PRNewswire/ -- MCO (MyComplianceOffice), a leading provider of compliance management software for financial services firms, has been named to Chartis Research's Financial Crime and Compliance50 (FCC50) for the second...

Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List

Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List

SAN FRANCISCO and SUZHOU, China, Dec. 7, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...

menu
menu